The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

(2015) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

The Role of Image Guided Biopsy Targeting in Patients with Atypical Small Acinar Proliferation

(2015) Dima Raskolnikov et al.   JOURNAL OF UROLOGY

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

(2015) Guillaume Ploussard et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens

(2014) Francesca Giunchi et al.   Clinical Genitourinary Cancer

Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer

(2014) Tatsuo Gondo et al.   EUROPEAN RADIOLOGY

The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance—Implication for Clinical Decision Making in the Real-life Setting

(2014) Luca Villa et al.   UROLOGY

Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: Active surveillance criteria

(2013) Giorgio Ivan Russo et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer

(2012) Yoshinobu Komai et al.   BJU INTERNATIONAL

Pathologic Prostate Cancer Characteristics in Patients Eligible for Active Surveillance: A Head-to-Head Comparison of Contemporary Protocols

(2012) Viacheslav Iremashvili et al.   EUROPEAN UROLOGY

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

(2012) Marc A. Dall’Era et al.   EUROPEAN UROLOGY

Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer

(2010) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial

(2010) Tineke Wolters et al.   JOURNAL OF UROLOGY

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

(2010) Claudia Testa et al.   NMR IN BIOMEDICINE

Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men

(2009) Roderick C.N. van den Bergh et al.   BJU INTERNATIONAL

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

(2009) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Protocols

(2009) C. Shad Thaxton et al.   UROLOGY